These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 8580565
41. Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer. Elisei R, Lorusso L, Piaggi P, Torregrossa L, Pellegrini G, Molinaro E, Agate L, Bottici V, Pani F, Cacciato Insilla A, Casella F, Ciampi R, Tognetti I, Materazzi G, Basolo F, Romei C. Eur J Endocrinol; 2015 Sep; 173(3):297-304. PubMed ID: 26034076 [Abstract] [Full Text] [Related]
49. Accumulation of thallium-201 in medullary thyroid cancer with negative serum calcitonin and carcinoembryonic antigens: a case report. Koizumi M, Watari T, Hirabayashi K. Ann Nucl Med; 1993 Feb; 7(1):53-6. PubMed ID: 8461239 [Abstract] [Full Text] [Related]
50. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. J Clin Endocrinol Metab; 2007 Feb; 92(2):450-5. PubMed ID: 17119000 [Abstract] [Full Text] [Related]
51. Medullary thyroid carcinoma with nodular goiter carries an excellent prognosis. Xu L, Wang WB, Zhao YP, Zhang TP, Liao Q, Chen G, Zhou L, Shu H. J Surg Oncol; 2012 Aug 01; 106(2):169-73. PubMed ID: 22354558 [Abstract] [Full Text] [Related]
52. The values of calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma. Rougier P, Calmettes C, Laplanche A, Travagli JP, Lefevre M, Parmentier C, Milhaud G, Tubiana M. Cancer; 1983 Mar 01; 51(5):855-62. PubMed ID: 6821852 [Abstract] [Full Text] [Related]
53. "Hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. Leboeuf R, Langlois MF, Martin M, Ahnadi CE, Fink GD. J Clin Endocrinol Metab; 2006 Feb 01; 91(2):361-4. PubMed ID: 16278263 [Abstract] [Full Text] [Related]
54. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC. J Clin Endocrinol Metab; 1994 Jan 01; 78(1):114-20. PubMed ID: 7904611 [Abstract] [Full Text] [Related]
56. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience. Lupone G, Antonino A, Rosato A, Zenone P, Iervolino EM, Grillo M, De Palma M. G Chir; 2012 Jan 01; 33(11-12):395-9. PubMed ID: 23140924 [Abstract] [Full Text] [Related]
57. Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin. Mirallié E, Iacobone M, Sebag F, Henry JF. Eur J Surg Oncol; 2004 Sep 01; 30(7):790-5. PubMed ID: 15296996 [Abstract] [Full Text] [Related]